This trial is for adults with IPF who are 40 years or older. It is testing whether BI 1015550 helps people with IPF.
1 Primary · 18 Secondary · Reporting Duration: up to 31 months
Experimental Treatment
Non-Treatment Group
963 Total Participants · 4 Treatment Groups
Primary Treatment: BI 1015550 - Treatment · Has Placebo Group · Phase 3
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: